glp-1 discovery Trends in the Development of Receptor Agonists Reflections on the discovery GLP-1

Although semaglutide (Ozempic, Wegovy) and other GLP-1 drugs have rapidly become infamous for a wide variety of common side effects, from diarrhea to Ozempic face, the most prominent warnings on their official U.S

Es sorgt dafr, dass der Krper mehr Insulin freisetzt, und verstrkt das Sttigungsgefhl

They might do perfectly fine on a fraction of the standard dosing schedules for years, keeping their metabolic markers in check without aggressive intervention

Current endpoint studies show that some GLP-1 receptor agonists also reduce the risk of cardiovascular and kidney disease (nephropathy) as well as reducing the premature mortality rate especially in persons with preexisting heart disease (moderate to high evidence level)